UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934

For the Month of ~~September~~November 2025

CAMTEK LTD. (Translation of Registrant’s Name into English)

Ramat Gavriel Industrial Zone P.O. Box 544 Migdal Haemek 23150 ISRAEL (Address of Principal ~~Executive~~Corporate Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

~~EXPLANATORY~~Indicate ~~NOTE~~by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities and Exchange Act of 1934.

OnYes ☐ No September 16, 2025, Camtek Ltd (Nasdaq: CAMT; TASE: CAMT) (the “Company”) closed its previously announced offering of $425,000,000 aggregate principal amount of 0.00% Convertible Senior Notes due 2030 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), including $75,000,000 of Additional Notes (as defined below) pursuant to the Initial Purchasers’ (as defined below) exercise in full of their option to purchase Additional Notes, resulting in a total aggregate principal amount of $500,000,000.☒

PURCHASE AGREEMENT

On September 11, 2025, the Company entered into a purchase agreement (the “Purchase Agreement”) with the representatives of the initial purchasers named therein (collectively, the “Initial Purchasers”), pursuant to which the Company agreed to sell $425,000,000 aggregate principal amount of its 0.00% convertible senior notes due 2030 (the “Initial Convertible Notes”) in a private placement pursuant to Rule 144A under the Securities Act. The Company also agreed to grant a 13-day option to the Initial Purchasers to purchase all or part of an additional $75,000,000 aggregate principal amount of its 0.00% convertible senior notes due 2030 (the “Additional Notes”), which has been exercised in full. The Initial Convertible Notes, together with the Additional Notes, are referred to herein as the “Notes.”

The Purchase Agreement includes customary representations, warranties and covenants. Under the terms of the Purchase Agreement, the Company has agreed to indemnify the Initial Purchasers against certain liabilities and contribute to payments which the Initial Purchasers may be required to make in respect of any such liabilities.

INDENTURE

The sale of the Notes closed on September 16, 2025. The Notes were issued pursuant to an indenture, dated September 16, 2025 (the “Indenture”), between the Company and U.S. Bank Trust Company, National Association, as trustee.

The Notes will not bear regular interest, and the principal amount of the Notes will not accrete.

The Notes are convertible based upon an initial conversion rate of 9.1455 of the Company’s ordinary shares, nominal (par) value of NIS 0.01 per share (the “ordinary shares”), per $1,000 principal amount of the Notes (equivalent to a conversion price of approximately $109.34 per ordinary share). The conversion rate will be subject to adjustment upon the occurrence of certain specified events. In addition, in connection with a make-whole fundamental change (as defined in the Indenture), or following the Company’s delivery of a notice of redemption, the Company will, in certain circumstances, increase the conversion rate for a holder who elects to convert its Notes in connection with such a corporate event or redemption, as the case may be.

The Notes will mature on September 15, 2030, unless earlier repurchased, redeemed or converted. Prior to the close of business on the business day immediately preceding June 15, 2030, a holder may convert its Notes only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on December 31, 2025 (and only during such calendar quarter), if the last reported sale price of the Company’s ordinary shares for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five business day period after any 10 consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the ordinary shares and the conversion rate on each such trading day; (3) if the Company calls the Notes for redemption in certain circumstances, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or (4) upon the occurrence of specified corporate events. On or after June 15, 2030, until the close of business on the second scheduled trading day immediately preceding the maturity date, a holder may convert its Notes at any time, regardless of the foregoing circumstances. Upon conversion, the Company will pay or deliver, as the case may be, cash, ordinary shares or a combination of cash and ordinary shares, at the Company’s election.

The Company may redeem for cash (1) all of the Notes at any time on or prior to the 40th scheduled trading day immediately preceding the maturity date if certain tax-related events occur and (2) all or any portion (subject to certain limitations) of the Notes, at any time, and from time to time, on or after September 20, 2028, and on or before the 40th scheduled trading day immediately before the maturity date, at its option at any time and from time to time, if the last reported sale price per ordinary share has been at least 130% of the conversion price for a specified period of time and certain other conditions are satisfied. For any Notes the Company redeems, the Company will pay a redemption price equal to the principal amount of the Notes redeemed (plus accrued and unpaid special interest, if any is payable at the time). Upon the occurrence of a fundamental change (as defined in the Indenture), holders may require the Company to repurchase for cash all or any portion of their Notes at a fundamental change repurchase price equal to 100% of the principal amount of the Notes to be repurchased, plus accrued and unpaid special interest, if any is payable at that time.

The Indenture contains customary terms and covenants, including that upon certain events of default occurring and continuing, either the Trustee or the holders of not less than 25% in aggregate principal amount of the Notes then outstanding may declare the entire principal amount of all the Notes plus accrued and unpaid special interest, if any, to be immediately due and payable.

The Notes are the Company’s senior unsecured obligations and rank senior in right of payment to any of the Company’s unsecured indebtedness that is expressly subordinated in right of payment to the Notes; equal in right of payment to any of the Company’s unsecured indebtedness that is not so subordinated, including the Company’s 0% Convertible Senior Notes 2026 (the “Existing Notes”); effectively junior in right of payment to any of the Company’s secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally junior to all indebtedness and other liabilities (including trade payables) of the Company’s subsidiaries. A copy of the Indenture and the form of the Notes are attached hereto as Exhibits 4.1 and 4.2, respectively, and are incorporated by reference herein. The foregoing summary does not purport to be complete and is qualified in its entirety by reference to the Indenture and the form of the Notes.

The net proceeds from the sale of the Notes were approximately $486.5 million, after deducting the Initial Purchasers’ discounts and the estimated offering expenses payable by the Company. The Company used approximately $267.0 million of the net proceeds to repurchase approximately $167.1 million aggregate principal amount of the Existing Notes on terms negotiated with each holder contemporaneously with the pricing of the Notes pursuant to one or more separate and individually negotiated transactions entered with one or more holders of the Existing Notes. The Company intends to use the remainder of the net proceeds for general corporate purposes, including, but not limited to potential acquisitions, working capital, capital expenditures, investments, and research and development.

UNREGISTERED SALE OF EQUITY SECURITIES

The Company’s offering of the Notes to the Initial Purchasers was made in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act. The Company relied on this exemption from registration based in part on representations made by the Initial Purchasers in the Purchase Agreement, including that the Initial Purchasers would only offer, sell or deliver the Notes to persons inside the United States whom they reasonably believed to be qualified institutional buyers within the meaning of Rule 144A under the Securities Act.

The Notes and the ordinary shares issuable upon conversion of the Notes, if any, have not been registered under the Securities Act and may not be offered or sold in the United States absent registration or applicable exemption from registration requirements.

Exhibit Number		Description of Exhibit
4.1		Indenture, dated as of September 16, 2025, between Camtek Ltd and U.S. Bank Trust Company, National Association, as trustee, for the 0.00% Convertible Senior Notes due 2030.
4.2		Form of 0.00% Convertible Senior Note due 2030 (included in Exhibit 4.1).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. This Form 6-K, including all exhibits hereto, is hereby incorporated by reference into all effective registration statements filed by the registrant under the Securities Act of 1933.

~~Date~~CAMTEK LTD. (Registrant) By: ~~September~~/s/ 16Moshe Eisenberg —————————————— Moshe Eisenberg, ~~2025~~Chief Financial Officer

~~CAMTEK LTD (Registrant) By~~Dated: ~~/s/~~November ~~Moshe~~10, ~~Eisenberg Name: Moshe Eisenberg Title: Chief Financial Officer~~2025

Camtek Ltd.

P.O.Box 544, Ramat Gabriel Industrial Park

Migdal Ha’Emek 23150, ISRAEL

Tel: +972 (4) 604-8100 Fax: +972 (4) 644-0523

E-Mail: Info@camtek.com Web site: http://www.camtek.com

CAMTEK LTD.

Moshe Eisenberg, CFO

Tel: +972 4 604 8308

Mobile: +972 54 900 7100

moshee@camtek.com

INTERNATIONAL INVESTOR RELATIONS

EK Global Investor Relations

Ehud Helft
Tel: (US) 1 212 378 8040

camtek@ekgir.com

FOR IMMEDIATE RELEASE

CAMTEK ANNOUNCES RECORD RESULTS

FOR THE THIRD QUARTER OF 2025

Another Strong Quarter Expected in Q4 with Revenues of around $127 million

MIGDAL HAEMEK, Israel – November 10, 2025 – Camtek Ltd. (NASDAQ: CAMT; TASE: CAMT), today announced its financial results for the third quarter ended September 30, 2025.

2025 Third Quarter Financial Highlights

•

Record revenues of $126.0 million, a 12% YoY increase;

•

GAAP gross margin of 50.0% and non-GAAP gross margin of 51.5%;

•

GAAP operating income of $31.8 million (up 8% YoY) and non-GAAP operating income of $37.6 million (up 10% YoY), representing operating margins of 25.3% and 29.9%, respectively;

•

$500 million raised via new offering of convertible notes;

•

The GAAP results include a one-time capital loss of $89 million, net, related to the repurchase of 83% of the 2021 convertible notes which led to a GAAP net loss of $53.2 million and EPS of $(1.16); non-GAAP net income of $40.9 million (up 10% YoY); non-GAAP diluted EPS of $0.82; and

•

Generated cash of over $34 million from operating activities.

Fourth Quarter Guidance

Based on current orders, sales pipeline, and ongoing customer engagements, Management expects Q4 2025 revenue to be around $127 million, representing annual 2025 revenues of $495 million, a record year for Camtek with expected strong growth of 15% over 2024.

Management Comment

Rafi Amit, Camtek’s CEO commented, “We are very pleased with our results and achievements this quarter. Similar to the prior quarters, Camtek continued to grow and deliver record performance, driven primarily by the ongoing increasing demand for high-performance computing for AI applications.”

Continued Mr. Amit, “With the recent industry-wide announcements regarding large scale investments in data centers and AI applications, supporting a positive outlook for sustained industry growth and wafer fab equipment spending, we anticipate that Camtek’s annual growth will continue in 2026. At this stage, we expect that the revenues will be more second half weighted, following a somewhat slower start to the year.”

Concluded Mr. Amit, “With Camtek’s leading market position and the cutting-edge technological capabilities that we have recently added, we are well positioned to capitalize on the massive AI investments and to pursue significant growth while increasing our market share over the coming years.”

Third Quarter 2025 Financial Results

Revenues for the third quarter of 2025 were $126.0 million. This compares to third quarter 2024 revenues of $112.3 million, a year-over-year growth of 12%.

Gross profit on a GAAP basis in the quarter totaled $63.0 million (50.0% of revenues), an increase of 13% compared to $55.9 million (49.7% of revenues) in the third quarter of 2024.

Gross profit on a non-GAAP basis in the quarter totaled $64.9 million (51.5% of revenues), an increase of 14% compared to $57.1 million (50.8% of revenues) in the third quarter of 2024.

Operating income on a GAAP basis in the quarter totaled $31.9 million (25.3% of revenues), an increase of 7% compared to $29.6 million (26.4% of revenues) in the third quarter of 2024.

Operating income on a non-GAAP basis in the quarter totaled $37.6 million (29.9% of revenues), an increase of 10% compared to $34.2 million (30.4% of revenues) in the third quarter of 2024.

During the third quarter, Camtek issued $500 million of 0% coupon convertible senior notes in a private offering and used some of the proceeds to repurchase notes from a prior offering. Consequently, a loss of $89 million was recorded in the GAAP results.

Net loss on a GAAP basis in the quarter, which includes the aforementioned loss, totaled $53.2 million, or ($1.16) per basic share, compared to net income of $32.7 million, or $0.66 per diluted share, in the third quarter of 2024.

Net income on a non-GAAP basis in the quarter totaled $40.9 million, or $0.82 per diluted share, an increase of 10% compared to a non-GAAP net income of $37.0 million, or $0.75 per diluted share, in the third quarter of 2024.

Cash and cash equivalents, short-term and long-term deposits, and marketable securities, as of September 30, 2025, were $794.0 million compared to $ 543.9 million as of June 30, 2025. During the third quarter, the Company generated an operating cash flow of $34.3 million. In addition, as mentioned earlier, Camtek raised $219 million, net, in new convertible debt, replacing a prior series of convertible debt.

Conference Call

Camtek will host a video conference call/webinar today via Zoom, on November 10, 2025 at 09:00 ET (16:00 Israel time). Rafi Amit, CEO, Moshe Eisenberg, CFO, and Ramy Langer, COO will host the call and will be available to answer questions after presenting the results.

To participate in the webinar, please register using the following link, which will provide access to the video call: https://us06web.zoom.us/webinar/register/WN_aq_SOaEvTAiVDABZPEc9Eg

For those wishing to listen via phone, following registration, the dial in link will be sent. For any problems in registering, please email Camtek’s investor relations a few hours in advance of the call.

For those unable to participate, a recording will be available on Camtek’s website at http://www.camtek.com within a few hours after the call.

A summary presentation of the quarterly results will also be available on Camtek’s website.

ABOUT CAMTEK LTD.

Camtek is a developer and manufacturer of high-end inspection and metrology equipment for the semiconductor industry. Camtek's systems inspect IC and measure IC features on wafers throughout the production process of semiconductor devices, covering the front and mid-end and up to the beginning of assembly (Post Dicing). Camtek's systems inspect wafers for the most demanding semiconductor market segments, including Advanced Interconnect Packaging, Heterogenous Integration, Memory and HBM, CMOS Image Sensors, Compound Semiconductors, MEMS, and RF, serving numerous industries’ leading global IDMs, OSATs, and foundries.

With manufacturing facilities in Israel and Germany, and eight offices around the world, Camtek provides state of the art solutions in line with customers' requirements.

This press release is available at http://www.camtek.com

This press release contains statements that may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on Camtek’s current beliefs, expectations and assumptions about its business and industry, all of which may change. Forward-looking statements can be identified by the use of words including “believe,” “anticipate,” “should,” “intend,” “plan,” “will,” “may,” “expect,” “estimate,” “project,” “positioned,” “strategy,” and similar expressions that are intended to identify forward-looking statements, including our expectations and statements relating to the compound semiconductors market and our position in this market and the anticipated timing of delivery of the systems. These forward-looking statements involve known and unknown risks and uncertainties that may cause the actual results, performance or achievements of Camtek to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Factors that may cause our actual results to differ materially from those contained in the forward-looking statements include, but are not limited to, the effects of the war situation in Israel, and the related evolving regional conflicts; the continued demand and future contribution of HPC, HBM and Chiplet applications and devices to the Company business resulting from, among other things, the field of AI surging worldwide across companies, industries and geographies; formal or informal imposition by countries of new or revised export and/or import and doing-business regulations or sanctions, including but not limited to changes in U.S. trade policies, changes or uncertainty related to the U.S. government entity list and changes in the ability to sell products incorporating U.S originated technology, which can be made without prior notice, and our ability to effectively address such global trade issues and changes; our dependency on the semiconductor industry and the risk that adverse economic conditions, reduced capital expenditures, or cyclical downturns may negatively impact our results; the concentration of our business in certain Asia Pacific countries, particularly China, Taiwan, and Korea, which may be subject to trade restrictions, regulatory changes, or geopolitical tensions; and those other factors discussed in our Annual Report on Form 20-F as published on March 19, 2025 as well as other documents filed by the Company with the SEC as well as other documents that may be subsequently filed by Camtek from time to time with the Securities and Exchange Commission. We caution you not to place undue reliance on forward-looking statements, which speak only as of the date hereof. Camtek does not assume any obligation to update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release unless required by law.

While we believe that we have a reasonable basis for each forward-looking statement contained in this press release, we caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, about which we cannot be certain. In addition, any forward-looking statements represent Camtek’s views only as of the date of this press release and should not be relied upon as representing its views as of any subsequent date. Camtek does not assume any obligation to update any forward-looking statements unless required by law.

This press release provides financial measures that exclude: (i) share based compensation expenses; (ii) acquisition related expenses and )iii) expenses related to the extinguishment of convertible notes, and are therefore not calculated in accordance with generally accepted accounting principles (GAAP). Management believes that these non-GAAP financial measures provide meaningful supplemental information regarding our performance. The presentation of this non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Management uses both GAAP and non-GAAP measures when evaluating the business internally and therefore felt it is important to make these non-GAAP adjustments available to investors.

CAMTEK LTD. and its subsidiaries

Consolidated Balance Sheets (Unaudited)

(In thousands)

	September 30,			December 31,
	2025			2024
	U.S. Dollars
Assets

Current assets
Cash and cash equivalents		199,671			126,224
Short-term deposits		382,450			231,000
Marketable securities		57,373			30,813
Trade accounts receivable, net		112,502			99,471
Inventories		126,492			111,204
Other current assets		21,337			21,347

Total current assets		899,825			620,059

Long-term deposits		20,000			26,000
Marketable securities		134,460			87,115
Long-term inventory		16,131			11,879
Deferred tax asset, net		10,858			3,090
Other assets, net		2,493			2,001
Property, plant and equipment, net		62,214			54,196
Intangible assets, net		10,736			13,357
Goodwill		74,345			74,345

Total non- current assets		331,237			271,983

Total assets		1,231,062			892,042

Liabilities and shareholders’ equity

Current liabilities
Trade accounts payable		33,232			46,630
Other current liabilities		85,463			77,280

Total current liabilities		118,695			123,910

Long-term liabilities
Deferred tax liabilities, net		-			5,606
Other long-term liabilities		15,220			15,366
Convertible notes		519,111			197,925
Total long-term liabilities		534,331			218,897

Total liabilities		653,026			342,807

Commitments and contingencies

Shareholders’ equity
Ordinary shares NIS 0.01 par value, 100,000,000 shares authorized at September 30, 2025, and at December 31, 2024;
47,858,633 issued shares at September 30, 2025, and 47,541,682 at December 31, 2024;
45,766,257 shares outstanding at September 30, 2025, and 45,449,306 at December 31, 2024		178			177
Additional paid-in capital		227,589			214,931
Accumulated other comprehensive income (loss)		1,520			203
Retained earnings		350,647			335,822
		579,934			551,133
Treasury stock, at cost (2,092,376 shares as of September 30, 2025, and December 31, 2024)		(1,898	)		(1,898	)

Total shareholders' equity		578,036			549,235

Total liabilities and shareholders' equity		1,231,062			892,042

CAMTEK LTD. and its subsidiaries

Consolidated Statements of Income (Unaudited)

(in thousands)

	Nine months ended September 30,						Three months ended September 30,						Year ended December 31,
	2025			2024			2025			2024			2024
	U.S. dollars						U.S. dollars						U.S. dollars
Revenues		367,948			311,941			125,993			112,340			429,234
Cost of revenues		181,731			160,122			62,951			56,484			219,283

Gross profit		186,217			151,819			63,042			55,856			209,951

Operating expenses:
Research and development		35,289			27,916			13,453			9,770			38,287
Selling, general and administrative		54,409			47,134			17,744			16,440			63,595
Total operating expenses		89,698			75,050			31,197			26,210			101,882

Operating income		96,519			76,769			31,845			29,646			108,069

Financial income, net		16,901			16,994			6,526			6,370			23,169
Other expenses		(100,932	)		-			(100,932	)		-			-

Income (loss) before income taxes		12,488			93,763			(62,561	)		36,016			131,238

Income tax benefit (expense)		2,337			(8,257	)		9,380			(3,273	)		(12,723	)

Net income (loss)		14,825			85,506			(53,181	)		32,743			118,515

Earnings per share information:	Nine months ended September 30,				Three months ended September 30,					Year ended December 31,
	2025		2024		2025			2024		2024
	U.S. dollars				U.S. dollars					U.S. dollars
Basic net earnings (loss) per share (in US dollars)		0.32		1.89		(1.16	)		0.72		2.62

Diluted net earnings (loss) per share (in US dollars)		0.32		1.73		(1.16	)		0.66		2.42

Weighted average number of
ordinary shares outstanding:

Basic		45,655		45,176		45,755			45,365		45,279

Diluted		49,502		49,333		45,755			49,437		49,369

Camtek Ltd.

Reconciliation of GAAP To Non-GAAP results

(In thousands, except share data)

	Nine Months ended September 30,						Three Months ended September 30,						Year ended December 31,
	2025			2024			2025			2024			2024
	U.S. dollars						U.S. dollars						U.S. dollars

Reported net income attributable to Camtek Ltd. on GAAP basis		14,825			85,506			(53,181	)		32,743			118,515
Acquisition of FRT-related expenses (1)		2,268			4,684			968			650			5,334
Loss from extinguishment of Capital Notes (2)		88,682			-			88,682			-			-
Share-based compensation		12,586			10,723			4,383			3,614			14,775
Non-GAAP net income		118,361			100,913			40,852			37,007			138,624

Non–GAAP net income per diluted share		2.42			2.05			0.82			0.75			2.83
Gross margin on GAAP basis		50.6	%		48.7	%		50.0	%		49.7	%		49.6	%
Reported gross profit on GAAP basis		186,217			151,819			63,042			55,856			209,951
Acquisition of FRT-related expenses (1)		2,285			5,192			1,065			610			5,802
Share-based compensation		2,094			1,602			750			596			2,197
Non- GAAP gross profit		190,596			158,613			64,857			57,062			217,950
Non-GAAP gross margin		51.8	%		50.8	%		51.5	%		50.8	%		50.8	%

Reported operating income attributable to Camtek Ltd. on GAAP basis		96,519			76,769			31,845			29,646			108,069
Acquisition of FRT related expenses (1)		3,239			6,527			1,383			928			7,455
Share-based compensation		12,586			10,723			4,383			3,614			14,775
Non-GAAP operating income		112,344			94,019			37,611			34,188			130,299

(1) During the nine-month period ended September 30, 2025, the Company recorded acquisition-related expenses of $2.3 million, consisting of: (1) inventory written-up to fair value in purchase accounting charges of $0.5 million. This amount is recorded under cost of revenues line item. (2) $1.8 million amortization of intangible assets acquired recorded under cost of revenues line item. (3) $1.0 million amortization of intangible assets acquired recorded under sales and marketing expenses line item. (4) $1.0 million reversal of tax provision related to the above adjustment, recorded under the tax expense line item.

During the three-month period ended September 30, 2025, the Company recorded acquisition-related expenses of $1.0 million, consisting of: (1) inventory written-up to fair value in purchase accounting charges of $0.5 million. This amount is recorded under cost of revenues line item. (2) $0.6 million amortization of intangible assets acquired recorded under cost of revenues line item. (3) $0.3 million amortization of intangible assets acquired recorded under sales and marketing expenses line item. (4) $0.4 million reversal of tax provision related to the above adjustment, recorded under the tax expense line item.

During the nine-month period ended September 30, 2024, the Company recorded acquisition-related expenses of $4.7 million, consisting of: (1) inventory written-up to fair value in purchase accounting charges of $3.4 million. This amount is recorded under cost of revenues line item. (2) $1.8 million amortization of intangible assets acquired recorded under cost of revenues line item. (3) $0.9 million amortization of intangible assets acquired recorded under sales and marketing expenses line item. (4) $0.4 million re-organization expenses, recorded under the general and administrative expenses line item. (5) $1.8 million reversal of tax provision related to the above adjustment, recorded under the tax expense line item.

During the three-month period ended September 30, 2024, the Company recorded acquisition-related expenses of $0.6 million, consisting of: (1) $0.6 million amortization of intangible assets acquired recorded under cost of revenues line item. (2) $0.3 million amortization of intangible assets acquired recorded under sales and marketing expenses line item. (3) $0.3 million reversal of tax provision related to the above adjustment, recorded under the tax expense line item.

During the year ended December 31, 2024, the Company recorded acquisition-related expenses of $5.3 million, consisting of: (1) inventory written-up to fair value in purchase accounting charges of $3.4 million. This amount is recorded under cost of revenues line item. (2) $2.4 million amortization of intangible assets acquired recorded under cost of revenues line item. (3) $1.3 million amortization of intangible assets acquired recorded under sales and marketing expenses line item. (4) $0.4 million re-organization expenses, recorded under the general and administrative expenses line item. (5) $2.1 million reversal of tax provision related to the above adjustment, recorded under the tax expense line item.

(2) During the nine-month and three-month periods ended September 30, 2025, the Company recorded a loss of $88.7 million, consisting of: (1) $100.9 million from the extinguishment of Capital Notes recorded under the other expenses line item. (2) $12.3 million tax benefit recorded under the income tax benefit line item.

Filing Compare · CAMTEK LTD